TerminatedPhase 2NCT00002921
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Studying Adrenocortical carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Louis E. Schroder, MD, M.D., Ph.DBarrett Cancer Center
- Intervention
- suramin(drug)
- Enrollment
- 13 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1997 – 2004
Study locations (30)
- MBCCOP - University of South Alabama, Mobile, Alabama, United States
- CCOP - Greater Phoenix, Phoenix, Arizona, United States
- Arizona Cancer Center, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Beckman Research Institute, City of Hope, Duarte, California, United States
- USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
- CCOP - Bay Area Tumor Institute, Oakland, California, United States
- Chao Family Comprehensive Cancer Center, Orange, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
- CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States
- University of Colorado Cancer Center, Denver, Colorado, United States
- CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
- CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002921 on ClinicalTrials.govOther trials for Adrenocortical carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06487481Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaNational Cancer Institute (NCI)
- RECRUITINGPHASE1NCT07189403A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerDaiichi Sankyo
- RECRUITINGPHASE2NCT06587802Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaSun Yat-sen University
- RECRUITINGNCT06279442Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian CohortLatin American Cooperative Oncology Group
- RECRUITINGPHASE2NCT06333314Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIUNICANCER
- RECRUITINGPHASE2NCT06066333Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaMemorial Sloan Kettering Cancer Center
- RECRUITINGPHASE2NCT05563467Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.Maria Sklodowska-Curie National Research Institute of Oncology
- RECRUITINGPHASE2NCT05913427Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia